Anti-obesity and anti-diabetic effects of mifepristone have been observed in both in humans and mice [4,5,6,7] For example, short-term treatment with mifepristone improved adipose and hepatic insulin sensitivity in obese human patients with hyperglycemia [6]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.